Formulating Expert Consensus Guidelines in Cancer Care Using the Delphi Method
NCT05054413 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 10
Last updated 2025-11-10
Summary
This study formulates consensus agreement on clinical key elements related to prostate cancer care that are critical for standardization and global reported using a robust Delphi technique, completely remote and electronic. The goal of this survey study is to have a panel of specialty-specific experts create a consensus agreement on a minimum set of key data elements for use in standardized reports. These recommendations would be used to develop standardized methods to report key data in electronic health records to better manage cancer patients at time of diagnosis, treatment, follow up, and into survivorship.
Conditions
- Hematopoietic and Lymphoid Cell Neoplasm
- Malignant Solid Neoplasm
Interventions
- OTHER
-
Questionnaire Administration
Complete questionnaires
Sponsors & Collaborators
-
M.D. Anderson Cancer Center
lead OTHER
Principal Investigators
-
Amy C Moreno · M.D. Anderson Cancer Center
Eligibility
- Min Age
- 21 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2021-04-15
- Primary Completion
- 2026-05-01
- Completion
- 2026-05-01
Countries
- United States
Study Locations
More Related Trials
-
Prospective Monitoring of Subjects With Biochemically Recurrent Prostate Cancer Using 18FDCFPyL
NCT05588128 ·Status: RECRUITING
-
Long-Term Follow-Up in Patients With Prostate Cancer After Surgery
NCT03035500 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Towards Optimal Prescription of Chemotherapy in Prostate Cancer
NCT02512185 ·Status: COMPLETED
-
Zoledronic Acid to Prevent Bone Loss During Androgen Deprivation Therapy for Prostate Cancer
NCT00181584 ·Status: COMPLETED ·Phase: PHASE2
-
Observational Longitudinal Study of Pain in Men With Metastatic Castrate-Resistant Prostate Cancer
NCT02008058 ·Status: COMPLETED
-
Multi-arm Multi-modality Therapy for Very High Risk Localized and Low Volume Metastatic Prostatic Adenocarcinoma
NCT03436654 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
A Study to Describe Patterns of Care and Outcomes of Men Who Are at High Risk After Experiencing Biochemical Failure Following Definitive Prostate Cancer Therapy, Men With Castration-resistant Prostate Cancer and Men With Metastatic Prostate Cancer
NCT02066961 ·Status: COMPLETED
-
Decision Support Interventions (DESI) for Prostate Cancer Screening and Treatment - Study 2
NCT01244568 ·Status: COMPLETED ·Phase: NA
-
Effect Of Zoledronic Acid On Circulating And Bone Marrow-Residing Prostate Cancer Cells In Patients With Clinically Localized Prostate Cancer
NCT00219271 ·Status: COMPLETED ·Phase: PHASE4
-
Lenalidomide and Cyclophosphamide in Treating Patients With Previously Treated Hormone-Refractory Prostate Cancer
NCT01093183 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
Active Surveillance in Prostate Cancer
NCT00490763 ·Status: COMPLETED
-
Hormonal Therapy and Chemotherapy Followed by Prostatectomy in Patients With Prostate Cancer
NCT02494713 ·Status: TERMINATED ·Phase: PHASE2
-
Study of Lenalidomide and Docetaxel in Subjects With Androgen Independent Prostate Cancer
NCT01378091 ·Status: COMPLETED ·Phase: PHASE1
-
PROSTATE-IQ: Parallel RandOmized STudy of Personalized Apalutamide Treatment and Evaluation to Improve Quality of Life in Post-Operative Radiation With Androgen Axis Suppression. A Phase III Multi-center Study for Men With Detectable PSA After Prostatectomy for Prostate Cancer.
NCT06274047 ·Status: RECRUITING ·Phase: PHASE3
-
Impact of Hormonal Therapy on Prostate Cancer Recurrence After Radical Prostatectomy
NCT05169112 ·Status: RECRUITING ·Phase: PHASE3
-
Genomic Biomarker-Selected Umbrella Neoadjuvant Study for High Risk Localized Prostate Cancer
NCT04812366 ·Status: RECRUITING ·Phase: PHASE2
-
Survey Based Discrete Choice Experiment Study in Prostate Cancer (DECIDER) Study
NCT05381311 ·Status: COMPLETED
-
Androgen Ablation Therapy With or Without Niraparib After Radiation Therapy for the Treatment of High-Risk Localized or Locally Advanced Prostate Cancer
NCT04947254 ·Status: RECRUITING ·Phase: PHASE2
-
Assessment of the Efficacy, Tolerability and Pharmaco-economic Impact of Zoledronic Acid Treatment in Prostate Cancer With Bone Metastasis
NCT00241111 ·Status: COMPLETED ·Phase: PHASE4
-
Two Studies for Patients With Unfavorable Intermediate Risk Prostate Cancer Testing Less Intense Treatment for Patients With a Low Gene Risk Score and Testing a More Intense Treatment for Patients With a Higher Gene Risk Score, The Guidance Trial
NCT05050084 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Phase 2 Study of G-202 in Patients With Chemotherapy-Naïve Metastatic Castrate-Resistant Prostate Cancer
NCT01734681 ·Status: WITHDRAWN ·Phase: PHASE2
-
Study of HPN424 in Patients With Advanced Prostate Cancer
NCT03577028 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
Monoclonal Antibody Therapy Plus Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy
NCT00009750 ·Status: UNKNOWN ·Phase: PHASE1
-
Aflibercept in Combination With Docetaxel in Metastatic Androgen Independent Prostate Cancer
NCT00519285 ·Status: COMPLETED ·Phase: PHASE3
-
GM-CSF for Maintenance of Prostate Cancer for Patients Responding to Taxotere
NCT00274287 ·Status: COMPLETED ·Phase: PHASE2